Cytokinetics CY6021: A Multi-Center, Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CK-3773274 in Adul

Project: Research project

Project Details

StatusActive
Effective start/end date5/27/205/27/23

Funding

  • ICON Clinical Research, LLC (Cytokinetics CY6021)
  • Cytokinetics, Inc. (Cytokinetics CY6021)